TrialEuropean journal of clinical pharmacology2016

Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.

Fadiea Al-Aieshy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.